The company installed a ZSE-3D twin screw extrusion system at its Somerville, NJ process laboratory.
On Aug. 27, 2018, Leistritz announced the installation of a ZSE-3D twin-screw extrusion system at its Somerville, NJ process laboratory. The system facilitates the development and production of 3D filaments from a co-rotating or counter-rotating twin screw extruder.
According to the company, direct extrusion of raw materials enables rapid product sampling and also results in one-less heat and shear history as compared to two-step processes, which is beneficial for heat and shear sensitive formulations.
The system features the following:
The company states that the system is suitable for in-line compounding of excipients with APIs, to quickly develop new filaments and formulations. Formulations can be modified extemporaneously for rapid sampling of filaments with different formulation percentages. A sample can be produced every 10 minutes. The filament system is configured for water-soluble and high-temperature applications.
Source: Leistritz
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.